NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · LARGE CAP
Embecta Corp. EMBC
6 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$1.1B
▼ 3.8% vs FY2024
EPS · FY25
$1.62
Dividend / sh · FY25
$0.60
Payout · FY25
37%
ROE · FY25
—
Net margin · FY25
8.8%
Dividend coverage
2.7×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 1.1B
Revenue, FY2025 · full 6-year series below
Revenue
Net income
9 cents of every revenue dollar became profit this year.
Per share
USD 1.62
Diluted EPS, FY2025
EPS
Dividend
Earnings covered the dividend 2.7 times — the rest stayed in the company.
Profitability
—
Return on equity, FY2025
ROE
Operating margin22.4%
Net margin8.8%
Return on assets8.0%
Returned to shareholders
USD 35.0M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 35.0M
Net buybacks—
Share of profit36.7%
Consecutive raises—
USD 35.0M in dividends — 37% of the year's profit went back to shareholders.
Growth
−0.1% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−1.5%
−0.1%
Net income
−24.7%
−25.9%
EPS, diluted
−25.3%
−26.4%
Dividend / share
+58.7%
Returned to shareholders
+59.7%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.06B
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 1.1B
total assets, end of FY2025
Total assetsUSD 1.1B
EquityUSD -650.6M
CashUSD 225.5M
Gross debtUSD 1.4B
Net debtUSD 1.2B
Current ratio2.41×
Net debt stands at -180% of equity.
History
6 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
Revenue $B
1.1
1.1
1.1
1.1
1.2
1.1
Operating income $B
0.2
0.2
0.2
0.3
0.5
0.5
EBITDA $B
0.3
0.2
0.3
0.3
0.5
0.5
Income tax $B
0.0
−0.0
0.0
0.0
0.1
0.1
Net income $B
0.1
0.1
0.1
0.2
0.4
0.4
EPS, diluted $
1.62
1.34
1.22
3.89
7.28
7.50
Dividend / sh $
0.60
0.60
0.60
0.15
·
·
Payout %
37
44
49
4
0
0
ROE %
·
·
·
·
71.1
74.7
Shares out B
0.06
0.06
0.06
0.06
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
22 of 22
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed